Summary
The global Benign Prostatic Hyperplasia (BPH) Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Alpha-blocker
Phosphodiesterase Type-5 Inhibitors
5-alpha-Reductase Inhibitors
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Astellas Pharma
Eli Lilly
GlaxoSmithKline
Sanofi
ADC Therapeutics
Bayer HealthCare
Bristol-Myers Squibb
Valeant Pharmaceuticals
Endo Pharmaceuticals
Foresee Pharmaceuticals
Madrigal Pharmaceuticals
Merck
Novartis
Spectrum Pharmaceuticals
Takeda Pharmaceuticals
Teva
Advaxis
ANI Pharmaceuticals
BHR Pharma
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospitals
Clinics
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Interested in this report?
Get your sample now!
Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Alpha-blocker
1.2.1.2 Phosphodiesterase Type-5 Inhibitors
1.2.1.3 5-alpha-Reductase Inhibitors
1.2.2 by Application
1.2.2.1 Hospitals
1.2.2.2 Clinics
1.2.2.3 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Alpha-blocker Market, 2013-2018
4.1.2 Phosphodiesterase Type-5 Inhibitors Market, 2013-2018
4.1.3 5-alpha-Reductase Inhibitors Market, 2013-2018
4.2 Market Forecast
4.2.1 Alpha-blocker Market Forecast, 2019-2024
4.2.2 Phosphodiesterase Type-5 Inhibitors Market Forecast, 2019-2024
4.2.3 5-alpha-Reductase Inhibitors Market Forecast, 2019-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospitals Market, 2013-2018
5.1.2 Clinics Market, 2013-2018
5.1.3 Others Market, 2013-2018
5.2 Market Forecast
5.2.1 Hospitals Market Forecast, 2019-2024
5.2.2 Clinics Market Forecast, 2019-2024
5.2.3 Others Market Forecast, 2019-2024
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Astellas Pharma
8.2 Eli Lilly
8.3 GlaxoSmithKline
8.4 Sanofi
8.5 ADC Therapeutics
8.6 Bayer HealthCare
8.7 Bristol-Myers Squibb
8.8 Valeant Pharmaceuticals
8.9 Endo Pharmaceuticals
8.10 Foresee Pharmaceuticals
8.11 Madrigal Pharmaceuticals
8.12 Merck
8.13 Novartis
8.14 Spectrum Pharmaceuticals
8.15 Takeda Pharmaceuticals
8.16 Teva
8.17 Advaxis
8.18 ANI Pharmaceuticals
8.19 BHR Pharma
9 Conclusion
Figure Benign Prostatic Hyperplasia (BPH) Drugs Picture
Figure Industry Chain Structure of Benign Prostatic Hyperplasia (BPH) Drugs
Figure SWOT of Benign Prostatic Hyperplasia (BPH) Drugs
Figure Alpha-blocker Market Size and Growth, 2012-2018 (USD Million)
Figure Alpha-blocker Market Size and Growth, 2012-2018 (in Volume)
Figure Phosphodiesterase Type-5 Inhibitors Market Size and Growth, 2012-2018 (USD Million)
Figure Phosphodiesterase Type-5 Inhibitors Market Size and Growth, 2012-2018 (in Volume)
Figure 5-alpha-Reductase Inhibitors Market Size and Growth, 2012-2018 (USD Million)
Figure 5-alpha-Reductase Inhibitors Market Size and Growth, 2012-2018 (in Volume)
Figure Alpha-blocker Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Alpha-blocker Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Phosphodiesterase Type-5 Inhibitors Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Phosphodiesterase Type-5 Inhibitors Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure 5-alpha-Reductase Inhibitors Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure 5-alpha-Reductase Inhibitors Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Hospitals Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Clinics Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Benign Prostatic Hyperplasia (BPH) Drugs Market Concentration by Region
Figure Marketing Channels Overview
